Susan D Wolf, MD
Dermatology · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 2 carriers
- Offices
- 2
Offices
2 locations · Csi Medical Group · 104 clinicians in this group
Plans that list them
4 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wolf’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A66326 · Current
Licensed to practise in California · since 1998 · expires 2028-07-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$180,933
Medicare paid this office $180,933 for 755 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 609 | $62,432 | $75 |
| Destruction of precancer skin growth, 1 growth | 473 | $34,325 | $56 |
| Biopsy of related skin growth, first growth | 152 | $14,070 | $86 |
| Destruction of precancer skin growth, 2-14 growths | 381 | $13,433 | $7 |
| New patient visit (30+ min) | 88 | $6,847 | $78 |
See all 16 services
| Short return visit (20+ min) | 609 | $62,432 | $75 |
| Destruction of precancer skin growth, 1 growth | 473 | $34,325 | $56 |
| Biopsy of related skin growth, first growth | 152 | $14,070 | $86 |
| Destruction of precancer skin growth, 2-14 growths | 381 | $13,433 | $7 |
| New patient visit (30+ min) | 88 | $6,847 | $78 |
| Return visit (30+ min) | 53 | $5,885 | $107 |
| Destruction of skin growth, 1-14 growths | 43 | $4,370 | $99 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $4,316 | $308 |
| Destruction of precancer skin growth, 15 or more growths | 21 | $3,879 | $162 |
| Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | 16 | $3,484 | $166 |
| Short return visit | 40 | $1,986 | $50 |
| Simple or single drainage of skin abscess | 13 | $1,559 | $120 |
| Biopsy of related skin growth, each additional growth | 20 | $1,286 | $51 |
| Injection into skin growth, 1-7 growths | 12 | $694 | $46 |
| New patient visit (15+ min) | 11 | $465 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $11 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 697 | More than 90% of doctors who do this |
| Removal or shaving of skin growth | 16 | More than 69% of doctors who do this |
| Skin biopsy | 129 | More than 79% of doctors who do this |
Who their Medicare patients are
755 Original Medicare patients in 2024. Average age 77 · Women 54% · Health risk score 0.84. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 63% · Cancer 18% · Coronary heart disease 17% · Atrial fibrillation 17% · Diabetes 15% · Chronic kidney disease 15% · Depression 9% · Heart failure 8% · COPD 8% · Stroke 5% · Dementia 4%.
The office billed $411,225, Medicare allowed $253,132 and paid $180,933; for 4,178 services of 58 kinds; $11 of it was for drugs given in the office and $180,922 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 755 | 4,178 | 77 | 0.84 | $411,225 | $180,933 |
| 2023 | 757 | 4,540 | 77 | 0.87 | $473,680 | $203,060 |
| 2022 | 727 | 3,463 | 77 | 0.88 | $373,987 | $160,605 |
| 2021 | 585 | 3,353 | 76 | 0.83 | $327,704 | $145,562 |
| 2020 | 516 | 3,285 | 76 | 0.92 | $295,215 | $127,563 |
| 2019 | 795 | 4,212 | 77 | 0.92 | $389,390 | $169,922 |
| 2018 | 758 | 3,523 | 77 | 0.94 | $397,397 | $165,933 |
| 2017 | 736 | 3,723 | 77 | 0.97 | $399,679 | $159,918 |
| 2016 | 775 | 4,348 | 77 | 0.96 | $510,285 | $194,744 |
| 2015 | 1,195 | 7,654 | 77 | 1.03 | $1,654,957 | $764,513 |
| 2014 | 1,125 | 6,463 | 77 | 0.95 | $812,320 | $351,618 |
| 2013 | 827 | 4,270 | 77 | 0.87 | $455,983 | $198,666 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Short return visit (20+ min) | 605 | $64,521 | $74 |
| Destruction of precancer skin growth, 1 growth | 466 | $34,004 | $53 |
| Destruction of precancer skin growth, 2-14 growths | 383 | $14,463 | $7 |
| Biopsy of related skin growth, first growth | 142 | $14,102 | $90 |
| New patient visit (30+ min) | 108 | $9,303 | $86 |
| Return visit (30+ min) | 54 | $6,329 | $105 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 18 | $5,342 | $281 |
| Destruction of skin growth, 1-14 growths | 41 | $4,343 | $106 |
| Short return visit | 63 | $3,529 | $50 |
| Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | 15 | $3,280 | $156 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | 16 | $3,223 | $179 |
| Simple or single drainage of skin abscess | 24 | $2,711 | $113 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 15 | $2,679 | $167 |
| Biopsy of related skin growth, each additional growth | 36 | $2,198 | $51 |
| Destruction of precancer skin growth, 15 or more growths | 12 | $1,986 | $166 |
| Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | 13 | $1,985 | $132 |
| Punch biopsy, first skin growth | 11 | $1,414 | $129 |
| Injection into skin growth, 1-7 growths | 20 | $767 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $20 | None |
2022: 14 services
| Short return visit (20+ min) | 553 | $57,621 | $74 |
| Destruction of precancer skin growth, 1 growth | 420 | $27,882 | $54 |
| New patient visit (30+ min) | 145 | $11,771 | $81 |
| Biopsy of related skin growth, first growth | 112 | $11,463 | $92 |
| Destruction of precancer skin growth, 2-14 growths | 331 | $9,531 | $7 |
| Destruction of skin growth, 1-14 growths | 36 | $4,188 | $102 |
| Return visit (30+ min) | 33 | $3,770 | $105 |
| Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | 18 | $3,332 | $151 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 13 | $2,135 | $152 |
| Short return visit | 39 | $1,953 | $48 |
| Simple or single drainage of skin abscess | 15 | $1,916 | $120 |
| Biopsy of related skin growth, each additional growth | 26 | $1,601 | $50 |
| Injection into skin growth, 1-7 growths | 23 | $1,513 | $46 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $30 | None |
2021: 11 services
| Short return visit (20+ min) | 460 | $50,329 | $76 |
| Destruction of precancer skin growth, 1 growth | 360 | $25,718 | $53 |
| Biopsy of related skin growth, first growth | 123 | $12,677 | $95 |
| Destruction of precancer skin growth, 2-14 growths | 293 | $10,353 | $7 |
| New patient visit (30+ min) | 108 | $8,951 | $83 |
| Return visit (30+ min) | 43 | $3,062 | $65 |
| Destruction of skin growth, 1-14 growths | 29 | $2,963 | $102 |
| Short return visit | 33 | $2,301 | $50 |
| Biopsy of related skin growth, each additional growth | 20 | $1,723 | $54 |
| Injection into skin growth, 1-7 growths | 25 | $1,096 | $37 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | $30 | None |
2020: 12 services
| Return visit (30+ min) | 231 | $25,617 | $97 |
| Destruction of precancer skin growth, 1 growth | 341 | $23,926 | $50 |
| Short return visit (20+ min) | 296 | $20,641 | $55 |
| Biopsy of related skin growth, first growth | 108 | $10,777 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 284 | $9,643 | $6 |
| New patient visit (30+ min) | 57 | $3,979 | $70 |
| Biopsy of related skin growth, each additional growth | 35 | $3,054 | $53 |
| Destruction of skin growth, 1-14 growths | 23 | $2,590 | $108 |
| Short return visit | 33 | $1,300 | $37 |
| New patient visit (15+ min) | 20 | $1,156 | $58 |
| Injection into skin growth, 1-7 growths | 18 | $1,060 | $46 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $50 | None |
2019: 14 services
| Short return visit (20+ min) | 642 | $56,889 | $61 |
| Destruction of precancer skin growth, 1 growth | 453 | $29,815 | $51 |
| Biopsy of related skin growth, first growth | 154 | $14,977 | $89 |
| Destruction of precancer skin growth, 2-14 growths | 355 | $10,094 | $5 |
| New patient visit (30+ min) | 107 | $8,286 | $77 |
| Destruction of skin growth, 1-14 growths | 56 | $5,566 | $98 |
| Short return visit | 84 | $3,649 | $39 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 22 | $3,577 | $149 |
| Biopsy of related skin growth, each additional growth | 37 | $2,419 | $53 |
| Simple or single drainage of skin abscess | 17 | $1,924 | $107 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 14 | $1,692 | $121 |
| Destruction of precancer skin growth, 15 or more growths | 11 | $1,540 | $140 |
| Injection into skin growth, 1-7 growths | 12 | $835 | $46 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $36 | None |
2018: 14 services
| Short return visit (20+ min) | 618 | $56,408 | $63 |
| Destruction of precancer skin growth, 1 growth | 382 | $26,830 | $55 |
| Biopsy of single growth of skin and/or tissue | 150 | $15,481 | $96 |
| New patient visit (30+ min) | 81 | $7,390 | $91 |
| Destruction of precancer skin growth, 2-14 growths | 287 | $6,846 | $5 |
| Destruction of skin growth, 1-14 growths | 56 | $6,079 | $100 |
| Short return visit | 89 | $3,865 | $38 |
| Destruction of precancer skin growth, 15 or more growths | 20 | $3,045 | $145 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 12 | $2,113 | $151 |
| Simple or single drainage of skin abscess | 14 | $1,569 | $105 |
| Biopsy of each additional growth of skin and/or tissue | 28 | $1,269 | $32 |
| New patient visit (15+ min) | 19 | $1,021 | $54 |
| Injection into skin growth, 1-7 growths | 13 | $938 | $49 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $42 | None |
2017: 15 services
| Short return visit (20+ min) | 603 | $51,535 | $58 |
| Destruction of precancer skin growth, 1 growth | 387 | $26,573 | $51 |
| Biopsy of single growth of skin and/or tissue | 160 | $17,200 | $93 |
| New patient visit (30+ min) | 109 | $9,188 | $84 |
| Destruction of precancer skin growth, 2-14 growths | 323 | $8,207 | $5 |
| Destruction of skin growth, 1-14 growths | 42 | $4,902 | $109 |
| Short return visit | 101 | $4,615 | $38 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 22 | $4,435 | $153 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 12 | $2,710 | $159 |
| Biopsy of each additional growth of skin and/or tissue | 39 | $2,050 | $31 |
| Destruction of precancer skin growth, 15 or more growths | 13 | $1,893 | $135 |
| Simple or single drainage of skin abscess | 13 | $1,213 | $93 |
| New patient visit (15+ min) | 11 | $709 | $64 |
| Injection into skin growth, 1-7 growths | 11 | $514 | $40 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $24 | None |
2016: 16 services
| Short return visit (20+ min) | 644 | $58,655 | $58 |
| Destruction of precancer skin growth, 1 growth | 428 | $30,719 | $51 |
| Biopsy of single growth of skin and/or tissue | 217 | $23,754 | $90 |
| Destruction of precancer skin growth, 2-14 growths | 343 | $9,394 | $5 |
| New patient visit (30+ min) | 116 | $8,575 | $74 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 18 | $6,572 | None |
| Short return visit | 107 | $5,316 | $40 |
| Application of light to destroy precancer skin growth | 18 | $3,664 | $141 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 18 | $3,641 | $152 |
| Destruction of skin growth, 1-14 growths | 30 | $2,968 | $99 |
| Biopsy of each additional growth of skin and/or tissue | 62 | $2,961 | $30 |
| Destruction of precancer skin growth, 15 or more growths | 15 | $2,588 | $136 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 11 | $2,126 | $164 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 12 | $1,747 | $134 |
| Biopsy of ear | 12 | $860 | $61 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $34 | None |
2015: 29 services
| High dose rate electronic brachytherapy | 35 | $302,767 | $1,835 |
| Short return visit (20+ min) | 864 | $84,415 | $63 |
| Biopsy of single growth of skin and/or tissue | 383 | $41,599 | $88 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 32 | $41,559 | $281 |
| Destruction of precancer skin growth, 1 growth | 541 | $36,728 | $51 |
| Destruction of precancer skin growth, 15 or more growths | 148 | $33,208 | $143 |
| Destruction of skin growth, 1-14 growths | 194 | $27,085 | $101 |
| New patient visit (30+ min) | 267 | $23,285 | $87 |
| Short return visit | 177 | $13,612 | $40 |
| Destruction of precancer skin growth, 2-14 growths | 436 | $11,789 | $5 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 33 | $11,432 | None |
| Calculation of radiation therapy dose | 36 | $10,624 | $61 |
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $7,575 | $108 |
| Application of light to destroy precancer skin growth | 32 | $7,214 | $144 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 14 | $6,843 | $456 |
| Simple or single drainage of skin abscess | 40 | $5,115 | $107 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 14 | $5,106 | $365 |
| Biopsy of each additional growth of skin and/or tissue | 112 | $4,782 | $30 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 13 | $4,663 | $359 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 24 | $3,810 | $152 |
| Radiation treatment management, 5 treatment sessions | 14 | $3,611 | $164 |
| Biopsy of eyelid | 15 | $2,653 | $166 |
| Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 15 | $2,378 | $149 |
| Injection into skin growth, 1-7 growths | 42 | $2,269 | $41 |
| Biopsy of ear | 26 | $2,114 | $73 |
| New patient visit (15+ min) | 34 | $2,102 | $62 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 12 | $1,762 | $147 |
| Continuing radiation therapy consultation per week | 13 | $1,701 | $81 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 51 | $154 | None |
2014: 22 services
| Short return visit (20+ min) | 791 | $71,545 | $60 |
| Destruction of precancer skin growth, 1 growth | 521 | $40,482 | $57 |
| Biopsy of single growth of skin and/or tissue | 346 | $36,542 | $90 |
| Destruction of precancer skin growth, 15 or more growths | 159 | $30,889 | $142 |
| New patient visit (30+ min) | 306 | $26,728 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 425 | $22,225 | $10 |
| Destruction of skin growth, 1-14 growths | 155 | $17,919 | $101 |
| Short return visit | 186 | $11,375 | $39 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 25 | $6,978 | None |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 24 | $6,467 | $269 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $5,929 | $110 |
| Application of light to destroy precancer skin growth | 25 | $4,935 | $141 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 13 | $4,641 | $357 |
| Biopsy of each additional growth of skin and/or tissue | 109 | $4,601 | $30 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 29 | $4,161 | $139 |
| Simple or single drainage of skin abscess | 29 | $3,421 | $110 |
| New patient visit (15+ min) | 47 | $2,908 | $62 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 15 | $2,328 | $155 |
| Biopsy of ear | 26 | $2,023 | $75 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,785 | $149 |
| Injection into skin growth, 1-7 growths | 22 | $1,565 | $43 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 34 | $132 | None |
2013: 16 services
| Short return visit (20+ min) | 591 | $50,977 | $58 |
| Destruction of precancer skin growth, 1 growth | 396 | $34,228 | $67 |
| Biopsy of single growth of skin and/or tissue | 217 | $24,307 | $98 |
| New patient visit (30+ min) | 185 | $15,045 | $81 |
| Destruction of precancer skin growth, 2-14 growths | 329 | $11,340 | $6 |
| Destruction of skin growth, 1-14 growths | 62 | $7,309 | $107 |
| Short return visit | 141 | $7,279 | $38 |
| Destruction of precancer skin growth, 15 or more growths | 39 | $6,662 | $162 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 12 | $3,412 | $284 |
| Biopsy of each additional growth of skin and/or tissue | 61 | $3,328 | $30 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 17 | $2,481 | $146 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $2,080 | $160 |
| New patient visit (15+ min) | 33 | $1,802 | $55 |
| Biopsy of ear | 20 | $1,657 | $72 |
| Injection into skin growth, 1-7 growths | 19 | $775 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $36 | None |
Drugs they prescribed that Part D paid
$185,601
Pharmacies billed $185,601 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 716) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
670 generic and 46 brand-name prescriptions · $185,601 in drug cost · 63 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 23 | $84,919 | $3,692 |
| Betamethasone Valerate | 16 | $2,785 | $174 |
| Fluorouracil | 30 | $2,414 | $80 |
| Clobetasol Propionate | 13 | $1,343 | $103 |
| Mometasone Furoate | 70 | $1,292 | $18 |
See all 17 drugs
| Dupixent | 23 | $84,919 | $3,692 |
| Betamethasone Valerate | 16 | $2,785 | $174 |
| Fluorouracil | 30 | $2,414 | $80 |
| Clobetasol Propionate | 13 | $1,343 | $103 |
| Mometasone Furoate | 70 | $1,292 | $18 |
| Ketoconazole | 45 | $1,220 | $27 |
| Clindamycin Phosphate | 38 | $1,087 | $29 |
| Triamcinolone Acetonide | 94 | $916 | $10 |
| Hydrocortisone | 88 | $890 | $10 |
| Metronidazole | 19 | $854 | $45 |
| Betamethasone Dipropionate | 24 | $707 | $29 |
| Doxycycline Hyclate | 23 | $669 | $29 |
| Valacyclovir | 29 | $553 | $19 |
| Minocycline | 18 | $331 | $18 |
| Fluocinonide | 13 | $313 | $24 |
| Hydroxyzine | 27 | $228 | $8 |
| Imiquimod | 15 | $196 | $13 |
Year by year
| 2024 | 716 | 286 | 0% (0) | 6% | $185,601 |
| 2023 | 717 | 282 | 0% (0) | 7% | $144,393 |
| 2022 | 726 | 293 | 0% (0) | None | $138,233 |
| 2021 | 618 | 234 | None | 9% | $103,160 |
| 2020 | 670 | 222 | None | 6% | $66,931 |
| 2019 | 673 | 235 | 0% (0) | 10% | $72,175 |
| 2018 | 664 | 243 | None | 7% | $70,537 |
| 2017 | 702 | 270 | None | 9% | $69,913 |
| 2016 | 834 | 263 | None | 10% | $79,546 |
| 2015 | 787 | 287 | None | None | $71,662 |
| 2014 | 736 | 300 | 0% (0) | 15% | $62,523 |
| 2013 | 726 | 273 | None | None | $51,222 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Dupixent | 26 | $98,429 | $3,786 |
| Fluorouracil | 36 | $3,166 | $88 |
| Metronidazole | 30 | $2,128 | $71 |
| Ketoconazole | 72 | $1,998 | $28 |
| Triamcinolone Acetonide | 136 | $1,470 | $11 |
| Mometasone Furoate | 71 | $1,453 | $20 |
| Clindamycin Phosphate | 25 | $1,168 | $47 |
| Doxycycline Hyclate | 17 | $982 | $58 |
| Betamethasone Dipropionate | 21 | $914 | $44 |
| Clobetasol Propionate | 13 | $618 | $48 |
| Imiquimod | 16 | $615 | $38 |
| Hydrocortisone | 56 | $535 | $10 |
| Minocycline | 12 | $475 | $40 |
| Ciclopirox | 28 | $469 | $17 |
| Valacyclovir | 13 | $393 | $30 |
| Hydroxyzine | 17 | $256 | $15 |
2022: 17 drugs
| Dupixent | 29 | $101,118 | $3,487 |
| Fluorouracil | 41 | $3,730 | $91 |
| Metronidazole | 36 | $2,171 | $60 |
| Clindamycin Phosphate | 33 | $1,848 | $56 |
| Triamcinolone Acetonide | 135 | $1,407 | $10 |
| Mometasone Furoate | 45 | $1,139 | $25 |
| Ketoconazole | 46 | $928 | $20 |
| Betamethasone Dipropionate | 16 | $831 | $52 |
| Hydrocortisone | 99 | $654 | $7 |
| Imiquimod | 13 | $632 | $49 |
| Ciclopirox | 15 | $602 | $40 |
| Valacyclovir | 23 | $518 | $23 |
| Doxycycline Monohydrate | 12 | $442 | $37 |
| Ciclopirox | 12 | $370 | $31 |
| Spironolactone | 11 | $218 | $20 |
| Hydroxyzine | 12 | $186 | $15 |
| Nystatin | 12 | $154 | $13 |
2021: 17 drugs
| Dupixent | 25 | $81,008 | $3,240 |
| Fluorouracil | 20 | $2,190 | $109 |
| Ketoconazole | 22 | $1,860 | $85 |
| Betamethasone Dipropionate | 26 | $1,640 | $63 |
| Clindamycin Phosphate | 26 | $1,608 | $62 |
| Metronidazole | 22 | $1,317 | $60 |
| Triamcinolone Acetonide | 102 | $1,144 | $11 |
| Imiquimod | 27 | $1,132 | $42 |
| Mometasone Furoate | 48 | $922 | $19 |
| Ciclopirox | 31 | $888 | $29 |
| Ciclopirox | 13 | $598 | $46 |
| Fluocinolone Acetonide | 12 | $524 | $44 |
| Hydrocortisone | 61 | $472 | $8 |
| Hydroxyzine | 11 | $302 | $27 |
| Valacyclovir | 14 | $300 | $21 |
| Minocycline | 13 | $264 | $20 |
| Sulfamethoxazole-Trimethoprim | 12 | $158 | $13 |
2020: 20 drugs
| Dupixent | 13 | $39,996 | $3,077 |
| Fluocinolone Acetonide | 16 | $4,067 | $254 |
| Fluorouracil | 21 | $2,201 | $105 |
| Tacrolimus | 17 | $2,111 | $124 |
| Clindamycin Phosphate | 28 | $1,382 | $49 |
| Clobetasol Propionate | 30 | $1,235 | $41 |
| Doxycycline Hyclate | 21 | $1,187 | $57 |
| Betamethasone Dipropionate | 25 | $1,135 | $45 |
| Metronidazole | 14 | $1,058 | $76 |
| Ketoconazole | 20 | $960 | $48 |
| Triamcinolone Acetonide | 85 | $940 | $11 |
| Imiquimod | 19 | $886 | $47 |
| Ciclopirox | 36 | $874 | $24 |
| Mometasone Furoate | 38 | $858 | $23 |
| Valacyclovir | 28 | $602 | $21 |
| Hydrocortisone | 82 | $523 | $6 |
| Fluocinonide | 13 | $351 | $27 |
| Cephalexin | 18 | $191 | $11 |
| Prednisone | 13 | $93 | $7 |
| Finasteride | 11 | $75 | $7 |
2019: 20 drugs
| Dupixent | 13 | $41,133 | $3,164 |
| Fluocinolone Acetonide | 30 | $4,260 | $142 |
| Fluorouracil | 28 | $3,316 | $118 |
| Clindamycin Phosphate | 33 | $2,137 | $65 |
| Betamethasone Dipropionate | 17 | $2,057 | $121 |
| Metronidazole | 19 | $1,542 | $81 |
| Clobetasol Propionate | 29 | $1,253 | $43 |
| Mometasone Furoate | 40 | $1,180 | $29 |
| Ciclopirox | 45 | $1,098 | $24 |
| Fluocinonide | 23 | $875 | $38 |
| Ketoconazole | 19 | $722 | $38 |
| Triamcinolone Acetonide | 73 | $718 | $10 |
| Econazole Nitrate | 11 | $641 | $58 |
| Doxycycline Hyclate | 21 | $635 | $30 |
| Hydrocortisone | 60 | $555 | $9 |
| Imiquimod | 12 | $467 | $39 |
| Doxepin | 18 | $459 | $26 |
| Valacyclovir | 26 | $426 | $16 |
| Cephalexin | 18 | $140 | $8 |
| Finasteride | 12 | $79 | $7 |
2018: 20 drugs
| Dupixent | 12 | $36,707 | $3,059 |
| Fluocinolone Acetonide | 29 | $3,352 | $116 |
| Metronidazole | 25 | $2,753 | $110 |
| Clobetasol Propionate | 56 | $2,393 | $43 |
| Fluorouracil | 18 | $2,047 | $114 |
| Ciclopirox | 48 | $1,804 | $38 |
| Doxepin | 25 | $1,403 | $56 |
| Fluocinonide | 18 | $1,400 | $78 |
| Clindamycin Phosphate | 23 | $1,219 | $53 |
| Imiquimod | 17 | $992 | $58 |
| Triamcinolone Acetonide | 95 | $964 | $10 |
| Betamethasone Dipropionate | 13 | $830 | $64 |
| Mometasone Furoate | 28 | $732 | $26 |
| Doxycycline Hyclate | 13 | $527 | $41 |
| Valacyclovir | 25 | $495 | $20 |
| Hydrocortisone | 57 | $441 | $8 |
| Ketoconazole | 14 | $419 | $30 |
| Doxycycline Monohydrate | 11 | $332 | $30 |
| Sulfamethoxazole-Trimethoprim | 14 | $214 | $15 |
| Prednisone | 16 | $87 | $5 |
2017: 18 drugs
| Fluocinolone Acetonide | 29 | $6,050 | $209 |
| Clobetasol Propionate | 63 | $4,738 | $75 |
| Metronidazole | 21 | $2,383 | $113 |
| Econazole Nitrate | 18 | $1,818 | $101 |
| Fluorouracil | 13 | $1,672 | $129 |
| Ciclopirox | 47 | $1,512 | $32 |
| Triamcinolone Acetonide | 119 | $1,380 | $12 |
| Doxycycline Hyclate | 25 | $1,077 | $43 |
| Clindamycin Phosphate | 21 | $913 | $43 |
| Fluocinonide | 19 | $887 | $47 |
| Imiquimod | 18 | $883 | $49 |
| Valacyclovir | 28 | $729 | $26 |
| Mometasone Furoate | 21 | $640 | $30 |
| Betamethasone Dipropionate | 16 | $623 | $39 |
| Hydrocortisone | 50 | $483 | $10 |
| Ketoconazole | 14 | $304 | $22 |
| Cephalexin | 19 | $216 | $11 |
| Prednisone | 12 | $122 | $10 |
2016: 23 drugs
| Otezla | 12 | $31,948 | $2,662 |
| Clobetasol Propionate | 89 | $9,488 | $107 |
| Fluocinolone Acetonide | 36 | $7,541 | $209 |
| Desonide | 25 | $3,560 | $142 |
| Doxycycline Hyclate | 21 | $2,551 | $121 |
| Metronidazole | 19 | $2,119 | $112 |
| Econazole Nitrate | 16 | $1,995 | $125 |
| Triamcinolone Acetonide | 140 | $1,957 | $14 |
| Ciclopirox | 73 | $1,931 | $26 |
| Fluorouracil | 13 | $1,821 | $140 |
| Fluocinonide | 34 | $1,366 | $40 |
| Valacyclovir | 27 | $1,213 | $45 |
| Betamethasone Dipropionate | 18 | $992 | $55 |
| Clindamycin Phosphate | 27 | $904 | $33 |
| Imiquimod | 16 | $723 | $45 |
| Hydrocortisone | 54 | $624 | $12 |
| Doxycycline Monohydrate | 11 | $543 | $49 |
| Mometasone Furoate | 15 | $358 | $24 |
| Ketoconazole | 19 | $325 | $17 |
| Prednisone | 16 | $213 | $13 |
| Cephalexin | 13 | $197 | $15 |
| Mupirocin | 17 | $168 | $10 |
| Sulfamethoxazole-Trimethoprim | 11 | $165 | $15 |
2015: 19 drugs
| Fluocinolone Acetonide | 61 | $13,149 | $216 |
| Clobetasol Propionate | 60 | $7,208 | $120 |
| Desonide | 48 | $6,225 | $130 |
| Fluorouracil | 26 | $4,466 | $172 |
| Fluocinolone Acetonide | 13 | $4,223 | $325 |
| Triamcinolone Acetonide | 125 | $2,276 | $18 |
| Ciclopirox | 65 | $2,026 | $31 |
| Clindamycin Phosphate | 23 | $1,665 | $72 |
| Fluocinonide | 30 | $1,418 | $47 |
| Metronidazole | 13 | $1,411 | $109 |
| Doxycycline Monohydrate | 14 | $874 | $62 |
| Mometasone Furoate | 22 | $447 | $20 |
| Valacyclovir | 21 | $447 | $21 |
| Hydrocortisone | 38 | $272 | $7 |
| Doxepin | 11 | $199 | $18 |
| Mupirocin | 14 | $196 | $14 |
| Cephalexin | 18 | $118 | $7 |
| Prednisone | 17 | $108 | $6 |
| Hydroxyzine | 11 | $79 | $7 |
2014: 19 drugs
| Fluocinolone Acetonide | 45 | $8,668 | $193 |
| Doxycycline Hyclate | 40 | $6,980 | $175 |
| Desonide | 33 | $5,126 | $155 |
| Fluorouracil | 21 | $5,036 | $240 |
| Valtrex | 14 | $3,322 | $237 |
| Clobetasol Propionate | 59 | $3,237 | $55 |
| Doxycycline Monohydrate | 28 | $2,159 | $77 |
| Metronidazole | 19 | $1,985 | $104 |
| Ciclopirox | 46 | $1,643 | $36 |
| Clindamycin Phosphate | 19 | $1,531 | $81 |
| Fluocinonide | 32 | $1,423 | $44 |
| Triamcinolone Acetonide | 78 | $1,224 | $16 |
| Valacyclovir | 22 | $551 | $25 |
| Econazole Nitrate | 18 | $406 | $23 |
| Hydrocortisone | 42 | $364 | $9 |
| Mometasone Furoate | 14 | $270 | $19 |
| Prednisone | 20 | $188 | $9 |
| Hydroxyzine | 16 | $180 | $11 |
| Cephalexin | 18 | $133 | $7 |
2013: 20 drugs
| Desonide | 55 | $7,720 | $140 |
| Doxycycline Hyclate | 38 | $6,356 | $167 |
| Metronidazole | 26 | $3,182 | $122 |
| Clobetasol Propionate | 74 | $2,901 | $39 |
| Valtrex | 12 | $2,773 | $231 |
| Fluocinolone Acetonide | 32 | $2,770 | $87 |
| Fluorouracil | 12 | $2,705 | $225 |
| Ciclopirox | 38 | $1,608 | $42 |
| Clindamycin Phosphate | 21 | $1,605 | $76 |
| Triamcinolone Acetonide | 84 | $1,143 | $14 |
| Valacyclovir | 19 | $1,080 | $57 |
| Fluocinonide | 35 | $948 | $27 |
| Doxycycline Monohydrate | 15 | $660 | $44 |
| Econazole Nitrate | 17 | $415 | $24 |
| Hydroxyzine | 29 | $410 | $14 |
| Sulfamethoxazole-Trimethoprim | 12 | $351 | $29 |
| Hydrocortisone | 27 | $198 | $7 |
| Ketoconazole | 11 | $187 | $17 |
| Cephalexin | 18 | $117 | $6 |
| Prednisone | 19 | $77 | $4 |
Money from drug and device companies
$1,979 in 2025
| 2025 | 17 | 83 | None | $1,979 |
| 2024 | 16 | 109 | None | $2,423 |
| 2023 | 15 | 121 | None | $2,669 |
| 2022 | 14 | 101 | None | $2,186 |
| 2021 | 18 | 81 | None | $1,624 |
| 2020 | 12 | 35 | None | $770 |
| 2019 | 18 | 82 | None | $3,009 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Taltz | $383 | 13 payments
|
| Abbvie | Rinvoq | $285 | 13 payments
|
| LEO Pharma | Adbry | $196 | 17 payments
|
| Galderma Laboratories L.P. | Nemluvio | $172 | 5 payments
|
| Janssen Biotech | Tremfya | $154 | 7 payments
|
| Incyte | Opzelura | $139 | 5 payments
|
See all 83 published payments
| Abbvie | Meals · 2025-12-10 | Skyrizi | $25 |
| LEO Pharma | Meals · 2025-12-09 | Adbry | $14 |
| LEO Pharma | Meals · 2025-12-09 | Adbry | $14 |
| Pfizer | Meals · 2025-12-04 | Cibinqo | $24 |
| Abbvie | Meals · 2025-12-02 | Skyrizi | $19 |
| LEO Pharma | Meals · 2025-11-19 | Anzupgo | $5 |
| LEO Pharma | Meals · 2025-11-19 | Anzupgo | $5 |
| Abbvie | Meals · 2025-11-18 | Rinvoq | $29 |
| Galderma Laboratories L.P. | Meals · 2025-11-18 | Nemluvio | $8 |
| LEO Pharma | Meals · 2025-11-18 | Anzupgo | $4 |
| LEO Pharma | Meals · 2025-11-17 | Adbry | $14 |
| Galderma Laboratories L.P. | Meals · 2025-11-14 | Nemluvio | $13 |
| Novartis Pharmaceuticals | Meals · 2025-11-10 | Rhapsido | $29 |
| Incyte | Meals · 2025-11-06 | Opzelura | $28 |
| LEO Pharma | Meals · 2025-10-21 | Adbry | $9 |
| Lilly USA | Meals · 2025-10-08 | Taltz | $33 |
| Incyte | Meals · 2025-10-08 | Opzelura | $29 |
| Sun Pharmaceutical Industries | Meals · 2025-10-02 | Ilumya | $33 |
| Incyte | Meals · 2025-09-23 | Opzelura | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-09-10 | Libtayo | $33 |
| Sun Pharmaceutical Industries | Meals · 2025-09-09 | Winlevi | $27 |
| Janssen Biotech | Meals · 2025-09-03 | Tremfya | $14 |
| Galderma Laboratories L.P. | Meals · 2025-09-03 | Nemluvio | $33 |
| Abbvie | Meals · 2025-08-28 | Skyrizi | $30 |
| Lilly USA | Meals · 2025-08-26 | Taltz | $33 |
| Abbvie | Meals · 2025-08-20 | Rinvoq | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-08-20 | Dupixent | $15 |
| Arcutis Biotherapeutics | Meals · 2025-08-19 | Zoryve | $28 |
| Merz North America | Meals · 2025-08-18 | None | $33 |
| LEO Pharma | Meals · 2025-08-06 | Adbry | $19 |
| Organon | Meals · 2025-07-23 | Vtama | $31 |
| LEO Pharma | Meals · 2025-07-23 | Adbry | $10 |
| Abbvie | Meals · 2025-07-22 | Rinvoq | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-07-21 | Libtayo | $29 |
| LEO Pharma | Meals · 2025-07-18 | Adbry | $20 |
| Lilly USA | Meals · 2025-07-16 | Taltz | $30 |
| Pfizer | Meals · 2025-07-01 | Cibinqo | $27 |
| Janssen Biotech | Meals · 2025-06-10 | Tremfya | $31 |
| LEO Pharma | Meals · 2025-06-09 | Adbry | $10 |
| Lilly USA | Meals · 2025-06-04 | Taltz | $29 |
| Genzyme | Meals · 2025-06-03 | Dupixent | $21 |
| LEO Pharma | Meals · 2025-06-02 | Adbry | $14 |
| Abbvie | Meals · 2025-05-29 | Skyrizi | $20 |
| Galderma Laboratories L.P. | Meals · 2025-05-29 | Nemluvio | $9 |
| Janssen Biotech | Meals · 2025-05-27 | Tremfya | $25 |
| Lilly USA | Meals · 2025-05-23 | Ebglyss | $29 |
| Pfizer | Meals · 2025-05-20 | Cibinqo | $20 |
| Lilly USA | Meals · 2025-05-07 | Taltz | $27 |
| Abbvie | Meals · 2025-05-06 | Rinvoq | $6 |
| Genzyme | Meals · 2025-05-06 | Dupixent | $31 |
| Amgen | Meals · 2025-05-05 | Otezla | $49 |
| Abbvie | Meals · 2025-05-01 | Rinvoq | $22 |
| Lilly USA | Meals · 2025-04-29 | Taltz | $32 |
| Galderma Laboratories L.P. | Meals · 2025-04-29 | Nemluvio | $110 |
| Incyte | Meals · 2025-04-23 | Opzelura | $29 |
| Abbvie | Meals · 2025-04-16 | Rinvoq | $3 |
| Arcutis Biotherapeutics | Meals · 2025-04-09 | Zoryve | $24 |
| Ucb | Meals · 2025-04-08 | Bimzelx | $32 |
| Genzyme | Meals · 2025-04-02 | Dupixent | $33 |
| Janssen Biotech | Meals · 2025-03-31 | Tremfya | $19 |
| Janssen Biotech | Meals · 2025-03-31 | Tremfya | $11 |
| Pfizer | Meals · 2025-03-25 | Cibinqo | $29 |
| Lilly USA | Meals · 2025-03-21 | Taltz | $30 |
| LEO Pharma | Meals · 2025-03-19 | Adbry | $22 |
| Janssen Biotech | Meals · 2025-03-17 | Tremfya | $23 |
| Lilly USA | Meals · 2025-03-12 | Taltz | $31 |
| Abbvie | Meals · 2025-03-12 | Skyrizi | $21 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $25 |
| Pfizer | Meals · 2025-02-26 | Cibinqo | $21 |
| LEO Pharma | Meals · 2025-02-18 | Adbry | $5 |
| LEO Pharma | Meals · 2025-02-18 | Adbry | $14 |
| Lilly USA | Meals · 2025-02-12 | Taltz | $30 |
| Lilly USA | Meals · 2025-02-07 | Taltz | $29 |
| Incyte | Meals · 2025-02-06 | Opzelura | $28 |
| Biofrontera | Meals · 2025-02-04 | None | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-01-30 | Libtayo | $34 |
| Lilly USA | Meals · 2025-01-29 | Taltz | $26 |
| Lilly USA | Meals · 2025-01-29 | Taltz | $26 |
| Arcutis Biotherapeutics | Meals · 2025-01-27 | Zoryve | $21 |
| Abbvie | Meals · 2025-01-22 | Rinvoq | $31 |
| LEO Pharma | Meals · 2025-01-22 | Adbry | $8 |
| LEO Pharma | Meals · 2025-01-16 | Adbry | $10 |
| Janssen Biotech | Meals · 2025-01-14 | Tremfya | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,423
| Abbvie | Skyrizi | $497 | 17 payments
|
| Lilly USA | Taltz | $316 | 13 payments
|
| LEO Pharma | Adbry | $220 | 16 payments
|
| Janssen Biotech | Tremfya | $213 | 6 payments
|
| Ucb | Bimzelx | $206 | 17 payments
|
| Pfizer | Eucrisa | $181 | 11 payments
|
| Sun Pharmaceutical Industries | Ilumya | $147 | 5 payments
|
| Dermavant Sciences | Vtama | $126 | 5 payments
|
| Incyte | Opzelura | $105 | 5 payments
|
| Novartis Pharmaceuticals | Xolair | $90 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $78 | 1 payment
|
| Genzyme | Dupixent | $75 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $69 | 3 payments
|
| Amgen | Otezla | $45 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $37 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $17 | 1 payment
|
2023: $2,669
| LEO Pharma | Adbry | $432 | 27 payments
|
| Janssen Biotech | Tremfya | $377 | 9 payments
|
| AbbVie | Skyrizi | $375 | 17 payments
|
| Genzyme | Dupixent | $298 | 11 payments
|
| Lilly USA | Taltz | $219 | 9 payments
|
| Regeneron Healthcare Solutions | Dupixent | $201 | 10 payments
|
| Pfizer | Eucrisa | $190 | 11 payments
|
| Dermavant Sciences | Vtama | $156 | 6 payments
|
| Incyte | Opzelura | $153 | 10 payments
|
| Amgen | Otezla | $83 | 3 payments
|
| Sun Pharmaceutical Industries | Winlevi | $55 | 2 payments
|
| Ucb | Bimzelx | $46 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $42 | 2 payments
|
| Galderma Laboratories L.P. | None | $25 | 1 payment
|
| Journey Medical | None | $16 | 1 payment
|
2022: $2,186
| LEO Pharma | Adbry | $363 | 33 payments
|
| Abbvie | Skyrizi | $324 | 14 payments
|
| Regeneron Healthcare Solutions | Dupixent | $304 | 12 payments
|
| Pfizer | Cibinqo | $294 | 6 payments
|
| Janssen Biotech | Remicade | $260 | 12 payments
|
| Lilly USA | Taltz | $166 | 5 payments
|
| Ucb | Cimzia | $95 | 3 payments
|
| Incyte | Opzelura | $93 | 4 payments
|
| Allergan | None | $80 | 4 payments
|
| Amgen | Otezla | $64 | 2 payments
|
| Genzyme | Dupixent | $49 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $45 | 2 payments
|
| Sun Pharmaceutical Industries | Ilumya | $29 | 1 payment
|
| Journey Medical | Qbrexza | $20 | 1 payment
|
2021: $1,624
| AbbVie | Skyrizi | $278 | 12 payments
|
| Ucb | Cimzia | $199 | 7 payments
|
| LEO Pharma | Enstilar | $174 | 18 payments
|
| Regeneron Healthcare Solutions | Dupixent | $163 | 8 payments
|
| Janssen Biotech | Remicade | $129 | 7 payments
|
| Sun Pharmaceutical Industries | Blu-U | $120 | 5 payments
|
| Genzyme | Dupixent | $84 | 4 payments
|
| Lilly USA | Taltz | $83 | 3 payments
|
| Pfizer | Eucrisa | $68 | 3 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $59 | 3 payments
|
| Allergan | Botox | $54 | 3 payments
|
| Mayne Pharma | None | $45 | 1 payment
|
| Galderma Laboratories L.P. | Aklief | $38 | 2 payments
|
| Organogenesis | Puraply Antimicrobial | $33 | 1 payment
|
| VYNE Pharmaceuticals | Amzeeq | $26 | 1 payment
|
| Dermira | Qbrexza | $25 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $24 | 1 payment
|
| Incyte | Opzelura | $23 | 1 payment
|
2020: $770
| Sun Pharmaceutical Industries | Ilumya | $164 | 4 payments
|
| AbbVie | Skyrizi | $143 | 9 payments
|
| Pfizer | Eucrisa | $100 | 5 payments
|
| Lilly USA | Taltz | $87 | 4 payments
|
| VYNE Pharmaceuticals | Amzeeq | $45 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $45 | 2 payments
|
| Mayne Pharma | Doryx | $42 | 2 payments
|
| Janssen Biotech | Remicade | $42 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $34 | 2 payments
|
| Ucb | Cimzia | $31 | 1 payment
|
| Amgen | Otezla | $19 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $17 | 1 payment
|
2019: $3,009
| AngioDynamics | Evlt | $660 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $415 | 12 payments
|
| Pfizer | Eucrisa | $373 | 17 payments
|
| AbbVie | Humira | $361 | 12 payments
|
| Sun Pharmaceutical Industries | Ilumya | $302 | 6 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $164 | 4 payments
|
| Janssen Biotech | Tremfya | $155 | 7 payments
|
| Regeneron Healthcare Solutions | Dupixent | $143 | 3 payments
|
| Lilly USA | Taltz | $128 | 8 payments
|
| Janssen Scientific Affairs | Tremfya | $100 | 1 payment
|
| Mayne Pharma | Doryx | $52 | 2 payments
|
| EPI Health | Sitavig | $45 | 3 payments
|
| Mylan Pharmaceuticals | Olux | $24 | 1 payment
|
| Almirall | Seysara | $22 | 1 payment
|
| Genzyme | Dupixent | $21 | 1 payment
|
| Allergan | None | $16 | 1 payment
|
| Mission Pharmacal | None | $15 | 1 payment
|
| DUSA Pharmaceuticals | Levulan Kerastick | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1043206261
- Licence
- CA A66326California A66326: Current · expires 2028-07-31
- Trained
- Yale University School of Medicine, 1997
- Group
- Csi Medical Group
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 136 N San Mateo Dr, 2nd Floor, San Mateo, CA, 94401
- NPI first listed
- 2005-09-22
- NPI last updated
- 2024-03-20
- NPI record certified
- 2024-03-20
This is when the NPI record was last certified, not a medical board exam.